These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26725950)

  • 1. A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'.
    Wadzinski TJ; Gea KD; Miller SJ
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1025-1028. PubMed ID: 26725950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
    Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
    J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
    Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient and practical method for solid-phase synthesis of tripeptide-bearing glycopeptide antibiotics: combinatorial parallel synthesis of carboxamide derivatives of chloroorienticin B.
    Yasukata T; Shindo H; Yoshida O; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3033-6. PubMed ID: 12372495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the functional impact of the vancomycin C-ring aryl chloride.
    Pinchman JR; Boger DL
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4817-9. PubMed ID: 23880541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
    Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
    ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
    Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
    Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus.
    Sunduru N; Gupta L; Chauhan K; Mishra NN; Shukla PK; Chauhan PM
    Eur J Med Chem; 2011 Apr; 46(4):1232-44. PubMed ID: 21345548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.
    Pinchman JR; Boger DL
    J Med Chem; 2013 May; 56(10):4116-24. PubMed ID: 23617725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
    Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target-accelerated combinatorial synthesis.
    Nicolaou KC; Hughes R; Cho SY; Winssinger N; Labischinski H; Endermann R
    Chemistry; 2001 Sep; 7(17):3824-43. PubMed ID: 11575783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
    Crane CM; Boger DL
    J Med Chem; 2009 Mar; 52(5):1471-6. PubMed ID: 19209892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]-Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE.
    Silverman SM; Moses JE; Sharpless KB
    Chemistry; 2017 Jan; 23(1):79-83. PubMed ID: 27747932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature.
    Hiramatsu K; Igarashi M; Morimoto Y; Baba T; Umekita M; Akamatsu Y
    Int J Antimicrob Agents; 2012 Jun; 39(6):478-85. PubMed ID: 22534508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.